BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15933717)

  • 1. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
    Azuma Y; Arnaoutov A; Anan T; Dasso M
    EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
    Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
    Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO-2/3 regulates topoisomerase II in mitosis.
    Azuma Y; Arnaoutov A; Dasso M
    J Cell Biol; 2003 Nov; 163(3):477-87. PubMed ID: 14597774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes.
    Ryu H; Al-Ani G; Deckert K; Kirkpatrick D; Gygi SP; Dasso M; Azuma Y
    J Biol Chem; 2010 May; 285(19):14415-23. PubMed ID: 20228053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.
    Ryu H; Azuma Y
    J Biol Chem; 2010 Oct; 285(42):32576-85. PubMed ID: 20696768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
    Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
    Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.
    Lee MT; Bachant J
    DNA Repair (Amst); 2009 Apr; 8(4):557-68. PubMed ID: 19230795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.
    Ryu H; Furuta M; Kirkpatrick D; Gygi SP; Azuma Y
    J Cell Biol; 2010 Nov; 191(4):783-94. PubMed ID: 21079245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Condensin-dependent localisation of topoisomerase II to an axial chromosomal structure is required for sister chromatid resolution during mitosis.
    Coelho PA; Queiroz-Machado J; Sunkel CE
    J Cell Sci; 2003 Dec; 116(Pt 23):4763-76. PubMed ID: 14600262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
    Sachdev S; Bruhn L; Sieber H; Pichler A; Melchior F; Grosschedl R
    Genes Dev; 2001 Dec; 15(23):3088-103. PubMed ID: 11731474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of the C-Terminal Region on the Interaction of Topoisomerase II Alpha with Mitotic Chromatin.
    Antoniou-Kourounioti M; Mimmack ML; Porter ACG; Farr CJ
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic SUMO modification regulates mitotic chromosome assembly and cell cycle progression in Caenorhabditis elegans.
    Pelisch F; Sonneville R; Pourkarimi E; Agostinho A; Blow JJ; Gartner A; Hay RT
    Nat Commun; 2014 Dec; 5():5485. PubMed ID: 25475837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
    Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
    Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
    Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
    Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
    Ihara M; Yamamoto H; Kikuchi A
    Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIASgamma is required for faithful chromosome segregation in human cells.
    Díaz-Martínez LA; Giménez-Abián JF; Azuma Y; Guacci V; Giménez-Martín G; Lanier LM; Clarke DJ
    PLoS One; 2006 Dec; 1(1):e53. PubMed ID: 17183683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
    Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
    J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.